Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
1995 1
1998 1
1999 1
2001 2
2002 1
2003 1
2004 1
2005 2
2006 2
2008 1
2009 1
2010 1
2011 5
2012 2
2013 1
2014 2
2015 1
2016 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Alcohol-induced depersonalization.
Raimo EB, Roemer RA, Moster M, Shan Y. Raimo EB, et al. Biol Psychiatry. 1999 Jun 1;45(11):1523-6. doi: 10.1016/s0006-3223(98)00257-1. Biol Psychiatry. 1999. PMID: 10356638
BACKGROUND: A case of alcohol-induced depersonalization disorder is presented. The subject had experienced several depersonalization states following the consumption of alcohol rather than from a psychogenic etiology, and the episodes were transient, not chronic. .. …
BACKGROUND: A case of alcohol-induced depersonalization disorder is presented. The subject had experienced several depersonali …
Lamotrigine Uses in Psychiatric Practice.
Naguy A, Al-Enezi N. Naguy A, et al. Am J Ther. 2019 Jan/Feb;26(1):e96-e102. doi: 10.1097/MJT.0000000000000535. Am J Ther. 2019. PMID: 30601211 Review.
RESULTS: Sound evidence supports use of LAM for acute bipolar depression and prophylaxis, treatment-resistant schizophrenia, treatment-resistant obsessive-compulsive disorder, posttraumatic stress disorder, depersonalization disorder, and affective dysregulation and …
RESULTS: Sound evidence supports use of LAM for acute bipolar depression and prophylaxis, treatment-resistant schizophrenia, treatment-resis …
Depersonalization disorder: pharmacological approaches.
Sierra M. Sierra M. Expert Rev Neurother. 2008 Jan;8(1):19-26. doi: 10.1586/14737175.8.1.19. Expert Rev Neurother. 2008. PMID: 18088198 Review.
Depersonalization disorder (DPD) is a chronic and distressing condition with a prevalence in the general population between 0.8 and 2%. ...
Depersonalization disorder (DPD) is a chronic and distressing condition with a prevalence in the general population between 0. …
Depersonalization disorder and self-injurious behavior.
Simeon D, Stein DJ, Hollander E. Simeon D, et al. J Clin Psychiatry. 1995;56 Suppl 4:36-9; discussion 40. J Clin Psychiatry. 1995. PMID: 7713864 Review.
When episodes of depersonalization are recurrent or persistent and lead to distress or dysfunction, the diagnosis of depersonalization disorder is made. Certain similarities in phenomenology, comorbidity, neurochemistry, and treatment response suggest a relationship …
When episodes of depersonalization are recurrent or persistent and lead to distress or dysfunction, the diagnosis of depersonalization …
Psychophysiological investigations in depersonalization disorder and effects of electrodermal biofeedback.
Schoenberg PL, Sierra M, David AS. Schoenberg PL, et al. J Trauma Dissociation. 2012;13(3):311-29. doi: 10.1080/15299732.2011.606742. J Trauma Dissociation. 2012. PMID: 22545565 Clinical Trial.
Previous studies investigating depersonalization disorder (DPD) report a lower baseline skin conductance level (SCL) and attenuated skin conductance response (SCR) to emotive stimuli. ...Real-time versus sham biofeedback yielded a significant SCL increase after just …
Previous studies investigating depersonalization disorder (DPD) report a lower baseline skin conductance level (SCL) and atten …
Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
Uguz F, Sahingoz M. Uguz F, et al. Clin Neuropharmacol. 2014 Jul-Aug;37(4):125-7. doi: 10.1097/WNF.0000000000000036. Clin Neuropharmacol. 2014. PMID: 24992087
This report presents the successful treatment with aripiprazole of concurrent depersonalization disorder in 3 patients with depression or OCD. The psychiatric disorders were diagnosed through structured clinical interviews. ...Aripiprazole may be a beneficial …
This report presents the successful treatment with aripiprazole of concurrent depersonalization disorder in 3 patients with de …
Autonomic response in depersonalization disorder.
Sierra M, Senior C, Dalton J, McDonough M, Bond A, Phillips ML, O'Dwyer AM, David AS. Sierra M, et al. Arch Gen Psychiatry. 2002 Sep;59(9):833-8. doi: 10.1001/archpsyc.59.9.833. Arch Gen Psychiatry. 2002. PMID: 12215083
BACKGROUND: Emotional-processing inhibition has been suggested as a mechanism underlying some of the clinical features of depersonalization and/or derealization. In this study, we tested the prediction that autonomic response to emotional stimuli would be reduced in patien …
BACKGROUND: Emotional-processing inhibition has been suggested as a mechanism underlying some of the clinical features of depersonali …
Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder.
Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J. Simeon D, et al. Neuropsychopharmacology. 2001 Nov;25(5):793-5. doi: 10.1016/S0893-133X(01)00288-3. Neuropsychopharmacology. 2001. PMID: 11682263 Clinical Trial.
BACKGROUND: The purpose of this preliminary study was to investigate HPA axis function in dissociation. METHODS: Nine subjects with DSM-IV depersonalization disorder (DPD), without lifetime Posttraumatic Stress Disorder (PTSD) or current major depression, were compa …
BACKGROUND: The purpose of this preliminary study was to investigate HPA axis function in dissociation. METHODS: Nine subjects with DSM-IV …
Testing a neurobiological model of depersonalization disorder using repetitive transcranial magnetic stimulation.
Jay EL, Sierra M, Van den Eynde F, Rothwell JC, David AS. Jay EL, et al. Brain Stimul. 2014 Mar-Apr;7(2):252-9. doi: 10.1016/j.brs.2013.12.002. Epub 2013 Dec 12. Brain Stimul. 2014. PMID: 24439959 Free PMC article. Clinical Trial.
BACKGROUND: Depersonalization disorder (DPD) includes changes in subjective experiencing of self, encompassing emotional numbing. ...METHODS: Patients with medication-resistant DSM-IV DPD (N = 17) and controls (N = 20) were randomized to receive one session o …
BACKGROUND: Depersonalization disorder (DPD) includes changes in subjective experiencing of self, encompassing emotional numbi …
Development of a depersonalization severity scale.
Simeon D, Guralnik O, Schmeidler J. Simeon D, et al. J Trauma Stress. 2001 Apr;14(2):341-9. doi: 10.1023/A:1011169019614. J Trauma Stress. 2001. PMID: 11469161
Our aim was to develop a clinician-rated scale assessing depersonalization severity for use in clinical trials of Depersonalization Disorder and trauma-related disorders in general. The 6-item Depersonalization Severity Scale (DSS) was administered to 63 part …
Our aim was to develop a clinician-rated scale assessing depersonalization severity for use in clinical trials of Depersonalizatio …
27 results